Yair Kissin, MD
Orthopaedic Surgery · Hackensack, NJNPI 1619182276
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $120,345 of the $175,296 with a category attached, or 68.7%. Think Surgical, Inc. accounts for 86.1% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2021 at $48,389 and has fallen 74.5% since, to $12,333 in 2025. Among orthopaedic surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 234 payments — averaging $749.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Think Surgical, Inc.$151K
- Techmah Medical, LLC$9K
- Encore Medical, LP$4K
- KCI USA, Inc.$3K
- Zimmer Biomet$2K
- Pacira Pharmaceuticals Incorporated$2K
- plus $6K from 31 others
Across 3 payments — averaging $54,871 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Think Surgical, Inc.$147K
- Episurf Medical, Inc.$18K
What the payments were for
- Consulting fees$120,34569%
- Speaking & faculty fees$2,5001%
- Travel & lodging$41,81624%
- Food & beverage$10,3086%
- Education$3270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Think Surgical, Inc. | 100 | $150,957 |
| Techmah Medical, LLC | 3 | $8,540 |
| Encore Medical, LP | 8 | $4,103 |
| KCI USA, Inc. | 5 | $2,876 |
| Zimmer Biomet | 19 | $1,640 |
| Pacira Pharmaceuticals Incorporated | 8 | $1,502 |
| Heron Therapeutics, Inc. | 1 | $1,500 |
| Johnson & Johnson | 19 | $575 |
| Kerecis Limited | 5 | $447 |
| Miach Orthopaedics, Inc. | 2 | $430 |
| BD | 2 | $383 |
| Davol Inc. | 3 | $371 |
| Smith+Nephew | 4 | $250 |
| Seapearl East, Inc | 11 | $240 |
| Lima USA, Inc. | 3 | $210 |
| Ferring Pharmaceuticals Inc. | 12 | $194 |
| Limacorporate S.p.a. | 1 | $192 |
| Guard Medical Inc. | 1 | $124 |
| UOC USA Inc | 1 | $123 |
| Kinamed, Inc. | 1 | $98 |
| Vertex | 4 | $77 |
| Stryker | 1 | $56 |
| Pacira Therapeutics, Inc. | 3 | $51 |
| Sanara Medtech Inc. | 2 | $51 |
| Treace Medical Concepts, Inc. | 1 | $49 |
| Baxter Healthcare | 1 | $42 |
| Averitas Pharma Inc. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Royal Biologics, Inc. | 1 | $19 |
| Bioventus LLC | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| Intellijoint Surgical Inc. | 1 | $17 |
| Globus Medical | 1 | $16 |
| Heraeus Medical, LLC. | 1 | $16 |
| GRT US Holding, Inc. | 1 | $16 |
| Acera Surgical, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tsolution One Surgical System$115,905
- TMINI Miniature Robotic System$33,193
- SmartSpace Knee$8,540
- DJO Surgical 3DKnee System$1,997
- DJO Surgical Empowr Knee System$1,777
- DJO Surgical Exprt Revision Hip$1,500
- DJO Surgical TaperFill Hip System$1,500
- HTX-011$1,500
- EXPAREL$1,452
- PREVENA$800
- Kerecis SurgiClose$747
- Persona$685
- Kerecis Omega3 Marigen$448
- Persona Revision$327
- Gender Solutions Patellofemoral$327
- Product Portfolio$192
- Kerecis GraftGuide$187
- ROSA$178
- Kerecis Omega3 SurgiClose$149
- Kerecis Omega3 GraftGuide$149
How this compares
$175,296 in reported general payments places this provider in the 90th percentile of 587 orthopaedic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 83 | $3,173 |
| Meloxicam | 66 | $383 |
| Amoxicillin | 49 | $125 |
| Gabapentin | 12 | $90 |
| Celecoxib | 12 | $87 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Hackensack
- Michael KellyHackensack$9.7M
- Oscar VazquezHackensack$87K
- Thomas JohnHackensack$59K
- Luis GrauHackensack$53K
- Mark HartzbandParamus$9.4M
- Randal BetzLawrenceville$3M
- Luke AustinSewell$2.9M
- Kenneth MontgomeryMorristown$2.7M
- Zachary PostEgg Harbor Township$1.7M
- Harlan LevineMontvale$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.